Abstract
BackgroundThe discovery and development of immune checkpoint inhibitors (ICIs) revolutionized cancer treatment and cancer immunotherapy. However, the majority of patients with metastatic disease do not achieve durable response following treatment...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have